Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27032 | 197 | 42.4 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
69 | 27709 | CELL & TISSUE ENGINEERING//MESENCHYMAL STEM CELLS//PLURIPOTENCY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PARTHENOGENETIC EMBRYONIC STEM CELL | Author keyword | 2 | 67% | 1% | 2 |
2 | HEART DIS CARDIOTHORAC SURG | Address | 2 | 50% | 2% | 3 |
3 | PARTHENOGENETIC STEM CELLS | Author keyword | 1 | 40% | 1% | 2 |
4 | CLS21 | Address | 1 | 33% | 1% | 2 |
5 | BETA 2 M | Author keyword | 1 | 50% | 1% | 1 |
6 | BIOMED EXCELLENCE COBRE STEM CELL BIOL | Address | 1 | 50% | 1% | 1 |
7 | CAMBRIDGE UNIV TEACHING HOSP NHS FDN TRUST | Address | 1 | 50% | 1% | 1 |
8 | CAMPUS BENJAMIN FRANKLIN HOSP | Address | 1 | 50% | 1% | 1 |
9 | CHIMERISM INDUCTION | Author keyword | 1 | 50% | 1% | 1 |
10 | ECM MIMICKING | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIFFERENTIATED DERIVATIVES | 15 | 73% | 6% | 11 |
2 | PRIMATE PARTHENOTES | 6 | 100% | 2% | 4 |
3 | FETAL ANTIGENS | 1 | 100% | 1% | 2 |
4 | HUMAN PARTHENOGENETIC BLASTOCYSTS | 1 | 21% | 3% | 5 |
5 | IMMUNE REJECTION | 1 | 30% | 2% | 3 |
6 | MOUSE PARTHENOGENETIC EMBRYOS | 1 | 50% | 1% | 1 |
7 | ORGAN REPLACEMENT | 1 | 50% | 1% | 1 |
8 | INDUCED PLURIPOTENT | 1 | 13% | 2% | 4 |
9 | VITRO CULTURE CONDITIONS | 0 | 33% | 1% | 1 |
10 | SERUM REPLACEMENT MEDIUM | 0 | 10% | 2% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Immunogenicity of Pluripotent Stem Cells and Their Derivatives | 2013 | 17 | 108 | 23% |
Immunological considerations for embryonic and induced pluripotent stem cell banking | 2011 | 21 | 39 | 31% |
Immunogenicity of embryonic stem cell-derived progenitors after transplantation | 2011 | 9 | 41 | 46% |
Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations | 2011 | 13 | 84 | 33% |
In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages | 2011 | 9 | 75 | 33% |
Avoiding immunological rejection in regenerative medicine | 2015 | 1 | 155 | 10% |
Human parthenogenetic embryonic stem cells: one potential resource for cell therapy | 2009 | 14 | 21 | 29% |
Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells | 2011 | 10 | 146 | 21% |
How to cross immunogenetic hurdles to human embryonic stem cell transplantation | 2011 | 4 | 46 | 26% |
Parthenogenesis in non-rodent species: developmental competence and differentiation plasticity | 2012 | 4 | 56 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEART DIS CARDIOTHORAC SURG | 2 | 50% | 1.5% | 3 |
2 | CLS21 | 1 | 33% | 1.0% | 2 |
3 | BIOMED EXCELLENCE COBRE STEM CELL BIOL | 1 | 50% | 0.5% | 1 |
4 | CAMBRIDGE UNIV TEACHING HOSP NHS FDN TRUST | 1 | 50% | 0.5% | 1 |
5 | CAMPUS BENJAMIN FRANKLIN HOSP | 1 | 50% | 0.5% | 1 |
6 | FU WAI HOSPMINIST HLTH | 1 | 50% | 0.5% | 1 |
7 | IMPERIAL EXPT TRANSLAT MED | 1 | 50% | 0.5% | 1 |
8 | INSERM UMRS 976 | 1 | 50% | 0.5% | 1 |
9 | REPROD STEM CELL | 1 | 50% | 0.5% | 1 |
10 | SECT EXPT TUMOR IMMUNOL | 1 | 50% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000243165 | HUMAN EMBRYONIC STEM CELLS//HUMAN EMBRYONIC STEM CELL//FEEDER FREE CULTURE |
2 | 0.0000169050 | INDUCED PLURIPOTENT STEM CELLS//REPROGRAMMING//SOMATIC CELL REPROGRAMMING |
3 | 0.0000142964 | CARDIAC DIFFERENTIATION//STEM CELL REGENERAT MED CONSORTIUM//SOHNIS FAMILY CARDIAC ELE OPHYSIOL RE |
4 | 0.0000114211 | HEMANGIOBLAST//HEMOGENIC ENDOTHELIUM//AORTA GONAD MESONEPHROS |
5 | 0.0000097288 | NANOG//PLURIPOTENCY//OCT4 |
6 | 0.0000090614 | HLA A2 GENE//NONCLASSICAL MHC I//DRUG DESIGN DEV GRP |
7 | 0.0000084143 | GENOMIC IMPRINTING//H19//BECKWITH WIEDEMANN SYNDROME |
8 | 0.0000079557 | HAPLOID EMBRYONIC STEM CELLS//CHONGQING PIG IND SCI//INFLAMMATORY LEIOMYOSARCOMA |
9 | 0.0000072028 | NUCLEAR TRANSFER//SOMATIC CELL NUCLEAR TRANSFER//CLONING AND STEM CELLS |
10 | 0.0000070516 | MORAL STATUS//EMBRYO EXPERIMENTATION//MORAL ARROGANCE |